医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Aetna and Swiss Life Expand Partnership to Singapore

2013年10月31日 AM10:25
このエントリーをはてなブックマークに追加


 

SINGAPORE

Aetna (NYSE: AET), a leading global diversified health care solutions company, has been selected by Zurich-based Swiss Life, a leading life and pension insurer, to offer international health care benefits and services for expatriates out of Singapore to its roster of multinational customers, effective immediately.

Aetna’s expatriate health care plans replace Swiss Life Singapore’s in-house expatriate health care benefit plans.

The deal builds on the relationship announced in July that named Aetna as the United States partner for the Swiss Life Network, a global association of 60 insurance companies and business partners operating in 70 countries. Swiss Life offers comprehensive international and local employee benefit packages to multinational companies through the Swiss Life Network.

“We are pleased to expand our role in the Swiss Life Network to provide its customers in Singapore with high-quality expatriate employee benefits solutions and services tailored to meet their specific needs,” said Derek Goldberg, Aetna International’s general manager, Southeast Asia. “With our on-the-ground presence in Singapore and our strong global reach, we can provide the personalised, comprehensive service that multinational companies require to ensure their mobile employees have access to quality medical treatment so they can maintain good health.”

Aetna has been licensed to sell health insurance in Singapore since June, 2012. Aetna offers a variety of individual and group plans in the Singapore market, including its flagship International Health Care Plan for customers who need coverage across the globe and Aetna Healthy Aessentials for customers who need coverage across the Southeast Asia region.

Margrit Schmid, CEO of Swiss Life Network, said, “We are pleased to work with Aetna to offer our customers high-quality expat employee benefits in Singapore in addition to the U.S. As a leader in health care solutions in America and for the expatriate market, Aetna is known for its strength in care management, wellness and technology and its commitment to empowering people to live healthier lives. Our expanded relationship will allow us to enhance our ability to provide multinational companies with the very best in employee benefit packages.”

In December 2012, the Forum for Expatriate Management honored Aetna with an Asia-Pacific EMMA award for the most innovative use of technology in global mobility.

About Aetna International

Aetna International is committed to helping create a stronger, healthier global community by delivering comprehensive health benefits and health management solutions worldwide. Aetna International’s expatriate business is one of the industry’s largest and most prominent international health benefits providers, supporting more than 500,000 members worldwide with access to more than 100,000 hospitals, clinics and doctors in Aetna’s network of non-U.S. health care providers. The organization’s expatriate offerings include medical, dental, vision, life, disability and emergency assistance. Aetna International’s health management business collaborates with health care systems, government entities and plan sponsors around the world to design and build locally applied health management solutions to improve health, quality and cost outcomes. For more information, see www.aetnainternational.com.

About Aetna

Aetna is one of the United States’ leading diversified health care benefits companies, serving an estimated 44 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services, workers’ compensation administrative services and health information technology products and services. Aetna’s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com.

About Swiss Life

The Swiss Life Group is one of Europe’s leading comprehensive life and pensions and financial solutions providers. Swiss Life Holding Ltd, registered in Zurich, was founded in 1857 as Schweizerische Rentenanstalt. The shares of Swiss Life Holding Ltd are listed on the SIX Swiss Exchange (SLHN). The Swiss Life Group employs a workforce of around 7,000, with approximately 4,500 certified financial advisors.

The Swiss Life Group operates in Switzerland, Germany and France, and it has competency centres in Luxembourg, Liechtenstein and Singapore. The Group is also present in other European countries through Swiss Life Select, tecis, HORBACH, Proventus and Chase de Vere. For more information, see www.swisslife.com.

About Swiss Life Network

Swiss Life Network is a global association of 60 leading local life insurance companies and business partners. Through this network, Swiss Life offers comprehensive employee benefit solutions, including life insurance, pension and health solutions for over 400 multinational corporations in 70 countries and territories worldwide. The Swiss Life Network, founded 1962, is the leading global employee benefits network and a pioneer of the international risk pooling concept. Swiss Life Network has the objective to provide top-quality employee benefit solutions to multinational corporations around the globe for their international and local employee benefit needs. For more information, see www.swisslife-network.com.

CONTACT

Aetna
United States
Marnie Goodman, +1-860-273-2314
Goodmanm2@aetna.com
or
Hong
Kong
Vicky Lee, +852-2860-8012
LeeV3@aetna.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表